Opportunities for Healthy Volunteers
Contribute to medical research by participating in studies designed for healthy participants in your selected area.
↓
Matched clinical trials
Study on Durvalumab for Patients with Poor General Condition and Advanced Non-Small Cell Lung Cancer
Not recruiting
Investigated Diseases:Investigated Drugs:
Study of Encorafenib and Binimetinib for Patients with BRAFV600E-Mutant Metastatic Non-Small Cell Lung Cancer
Not recruiting
Investigated Diseases:Investigated Drugs:
Study on the Safety and Effectiveness of GB1211 and Atezolizumab for Patients with Non-Small Cell Lung Cancer
Not recruiting
Investigated Diseases:Investigated Drugs:
Study Comparing Ensartinib and Crizotinib for Patients with ALK-Positive Non-Small Cell Lung Cancer
Not recruiting
Investigated Diseases:Investigated Drugs:
+1
Study of Tisotumab Vedotin, Pembrolizumab, and Platinum Drug Combination for Patients with Advanced or Metastatic Solid Tumors
Not recruiting
Investigated Diseases:Investigated Drugs:
Study of Niraparib and Pembrolizumab for Patients with Advanced Non-Small Cell Lung Cancer
Not recruiting
Investigated Drugs:
+8
Study on Sotorasib for Patients with Advanced KRAS G12C-Mutated Non-Small Cell Lung Cancer and Comorbidities
Not recruiting
Investigated Drugs:
Study comparing brigatinib alone versus brigatinib with carboplatin and pemetrexed combination as first treatment for patients with advanced ALK-positive lung cancer
Not recruiting
Investigated Diseases:Investigated Drugs:
Study Comparing Nivolumab and Ipilimumab with Chemotherapy to Chemotherapy Alone for Patients with Stage IV Non-Small Cell Lung Cancer
Not recruiting
Investigated Diseases:Investigated Drugs:
+1
Study Comparing Ociperlimab and Tislelizumab with Pembrolizumab for Patients with Advanced Non-Small Cell Lung Cancer
Not recruiting
Investigated Diseases:Investigated Drugs: